Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial

References

Page 1

	Year	Citations
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) The Lancet ThrombosisIschaemic EventsCardiovascular DiseaseIschemic StrokeMedicine	1996	6.5K
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation New England Journal of Medicine	2001	6.4K
An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction New England Journal of Medicine	1993	4K
Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention Steven R. Steinhubl, Peter B. Berger, J. Tift Mann, JAMA	2002	3.1K
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events Deepak L. Bhatt, Keith A.A. Fox, Werner Hacke, New England Journal of Medicine	2006	2.8K
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Shamir R. Mehta, Salim Yusuf, Ron J.G. Peters, The Lancet Percutaneous Coronary InterventionThrombosisPci-cure StudyCardiovascular DiseaseCoronary Artery Disease	2001	2.8K
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee Martin Dennis The Lancet	1996	2.7K
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Shamir R. Mehta, Salim Yusuf, Ron J.G. Peters ACC Current Journal Review Percutaneous Coronary InterventionThrombosisPci-cure StudyCardiovascular DiseaseCoronary Artery Disease	2002	2.6K
Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial Z M Chen, Lixin Jiang, Y P Chen, The Lancet ThrombosisCardiovascular DiseaseMedicineCardiovascular PharmacologyPlacebo-controlled Trial	2005	1.9K
Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial Deepak L. Bhatt, Eric J. Topol American Heart Journal ThrombosisCardiovascular DiseaseBlood PlateletMedicineSecondary Prevention	2004	197

Page 1